N63S (p.Asn63Ser) variant of GRIA1 (Glutamate receptor 1)
N63S (p.Asn63Ser) in GRIA1 (Glutamate receptor 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
N63S (p.Asn63Ser) variant details
- p.Asn63Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.36
- MetaSVM -0.53
- SIFT 0.85
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available